Clinical Trial Update: Angiogenic Factors in the Placentas of Women With COVID-19

View source ↗

Summary

A completed clinical trial evaluating angiogenic factors in the placentas of pregnant women with COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Placental Disease

Snippet

Sponsor: Celal Bayar University | Conditions: COVID-19, Placenta Diseases | Status: COMPLETED